Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 2, 2022 | NTx | $200.0M Series C | Shaoqiang (Gary) Liu, CFA | — |
| May 19, 2021 | Duality Biologics | $90.0M Series B | Yi Shi | Green Pine Capital Partners, Huagai Capital, Oriza Holdings, WuXi Biologics, Yunion Healthcare Ventures |
| Jan 1, 2020 | Ronovo Surgical | $26.0M Series B Extension | Lin Xianghong | GGV Capital, Kington Capital, Lilly Asia Ventures, LongRiver Investments, Matrix Partners China, Vivo Capital |